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Abstract 
The interaction of charged particles with living matter needs to be well understood for 
medical applications. Particularly, it is useful to study how ion beams interact with tissues in 
terms of damage, dose released and dose rate. 
One way to evaluate the biological effects induced by an ion beam is by the irradiation of 
cultured cells at a particle accelerator, where cells can be exposed to different ions at different 
energies and flux.  
In this paper, we report the first results concerning the characterization of a broad proton 
beam obtained with our 2 MV tandem accelerator. For broad beam in vitro cell irradiation, the 
beam has to be stable over time, uniform over a ~0.5 cm² surface, and a dose rate ranging 
from 0.1 to 10 Gy/min must be achievable. Results concerning the level of achievement of 
these requirements are presented in this paper for a 1 MeV proton beam. 
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Introduction 
The interaction of charged particles with living matter has become increasingly interesting for 
medical applications like radiotherapy, radioprotection and space radiobiology [1-7]. In this 
field, particle accelerators are helpful due to the wide range of available ions, energies and 
flux. Dose fractionation can be also studied with an accelerator. Usually, two types of 
configuration are found: micro/nano beams and broad beams. A microbeam can precisely 
target a defined point on a cell or a group of cells. In this way, cytoplasm and/or nucleus 
irradiations can be performed [8-10]. However, cell recognition software, cell alignments and 
beam scanning need to be developed and subsequently makes the system very expensive. 
Moreover, focalised beam lines are generally operational for only two or three type of ions. 
On the other hand, broad beams [11, 12] allow the use of a wide range of ions. Thousands of 
cells can be irradiated simultaneously and additional stresses, like temperature effects, can be 
minimized. Unfortunately, with broad beam, particles Poisson distribution leads to dose error. 
With these set-ups studies like clonogenic assays or immunofluorescence can be performed 
and precious information can be inferred, especially for hadrontherapy.  
In 2007, the LARN laboratory (Laboratoire d’Analyses par Réactions Nucléaires) decided to 
develop a cheap in vitro irradiation station using broad beam. This paper reports preliminary 
results obtained for a proton beam. Cell irradiation experiments require the beam to possess 
certain properties. In our set-up, the beam must have a spatial uniformity of ± 5 % over an 
approximately 0.5 cm² surface and be stable during the irradiation. Indeed, for the same 
experiment, a homogeneous dose must be deposited within the cells and the dose rate must be 
constant. In this paper, we present the set-up, beam uniformity, beam stability and dose rate 
achievable with our system. Results of cell irradiation will be presented elsewhere. 
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Materials and Methods 
LARN facility 
The LARN accelerator is a 2 MV Tandem accelerator (High Voltage). It consists of three 
sections:  a dual source injecting system, a high voltage accelerating tube, a switching magnet 
with 5 beam lines. Due to two different sources, particles from Hydrogen to Uranium can be 
accelerated. Beam energy is determined by the terminal voltage, adjustable from 0.15 to 
2 MV.  
Once particles are accelerated, they enter the selected beam line. The irradiation beam line is 
equipped with a square collimator (1x1 cm²) and a pumping station, without any additional 
optical elements.  
Characterization set-up 
To perform radiobiological studies with a broad particle beam, the beam must be 
monoenergetic and homogeneous at least over an approximately 0.5 cm² surface in the air. 
These beam characteristics were measured with the set-up presented in Figure 1. It consists of 
a vacuum vessel with a square collimator, coupled to a turbomolecular pumping system, a 
specially designed irradiation head and a PIPS (Passivated Implated Planar Silicon) particle 
detector collimated with a 0.5 mm aperture mounted on a X-Y moving table. The detector is 
used to measure the flux to evaluate the stability and uniformity of the broad beam. The 
irradiation head includes an 8 µm Kapton foil maintained between two stainless steel 
cylinders. This head has two purposes: it acts both as an exit window for the beam and as a 
substrate for the cells to be irradiated in air. In our configuration, a window, 1.8 cm in 
diameter, seals the exit for more than 10 hours working with 1 MeV proton beam.  
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Dose and dose rate assessment 
Basic studies in radiobiology and particularly survival fraction studies, are performed at doses 
ranging from 0.1 to 10 Gy [3,7, 14-17] and with a dose rate ranging from 0.1 to 10 Gy/min. 
This range of dose rates also allows us to study low dose rates and low dose hypersensitivity 
[17-19]. For an ion beam, the dose rate can be related to the flux through the formula: 
91.610 (Gy/s)
LET
D


  
Where D is the dose rate (Gy/s), LET is the linear energy transfer (keV/µm),  is the flux 
(particles.s
-1
.cm
-
²) and  is the density of the cells (g/cm³). Taking into account the voltage 
range of our accelerator and the energy loss in the 8 µm exit window, the LET of a proton 
hitting a monolayer of cells can be adjusted from 10 keV/µm (terminal voltage: 1.9 MV) to 
50 keV/µm (terminal voltage: 305 kV) according to SRIM [13] calculations (cells=1g/cm³).  
The LET yields a maximum relative biological effectiveness (RBE) at 30 keV/µm [15, 16], 
which corresponds to 500 kV at the terminal voltage. The beam properties presented in this 
paper are obtained with this terminal voltage value.  
 
Results and discussion 
Stability and spatial uniformity of the proton beam 
Beam stability and spatial uniformity were checked with the set-up presented in Figure 1. 
Figure 2 presents the proton beam stability for a given dose rate for more than 10 minutes. 
Standard deviation was 2.6 %. Conversion between flux and dose rate was achieved by 
employing the equation above with a LET=30 keV/µm and cells=1 g/cm³. Proton beam spatial 
uniformity is presented in Figure 3. Dose rate was measured every millimetre, line by line, by 
moving the collimated PIPS detector with the X-Y table over a 12 mm excursion. One can 
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recognise a clear 1x1 cm² collimated beam. The irradiation field with a dose rate variation 
below ± 5 % is 8x8 mm², large enough for broad beam in vitro cell irradiation.  
 
Dose rate assessment  
Dose rate variation was studied with the same set-up (Figure 1). The beam flux was tuned by 
tuning the accelerator source ioniser current. Dose rate ranging from less than 0.1Gy/min to 
more than 10Gy/min can be achieved with a variation in the ioniser current of about 3 A. 
Figure 4 shows the dose rate versus ioniser current. Dose rates ranging from 0.26 to 15.9 
Gy/min are presented in this figure.  
 
Conclusion and future developments 
The results presented in this paper concerned a 1 MeV proton beam. These show that the 
LARN facility can be adapted for in vitro cell irradiation with a broad proton beam. Indeed, 
dose rates ranging from 0.1 to 10Gy/min are achievable by varying the source ioniser current. 
A stable and spatially uniform beam over a 8x8 mm² surface is easily obtained. Cell 
irradiations are currently performed. 
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Figures 
 
Figure 1: Experimental set-up for broad beam characterization. 1) Beam, 2) Pumping system, 3) 
Irradiation head, 4) 0.5mm collimated PIPS detector, 5) X/Y axes, 6) Stainless steel cylinders, 7) 8µm 
Kapton foil (exit window) 
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Figure 2: Proton beam stability versus time 
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Figure 3: 1MeV proton beam uniformity map 
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Figure 4: Dose rate and flux measurement of a 1 MeV proton beam versus source ioniser current 
